Energy
Big chase for a cancer drug: The urgent need for affordable Keytruda alternatives
Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, Indian companies are developing more affordable versions. Efforts are also focused on expanding indications and improving financial access.
Please first to comment
Stay Connected
Tweets by elonmuskTo get the latest tweets please make sure you are logged in on X on this browser.
